Trial Profile
Long-term effect of latanoprost on central corneal thickness (CCT) in patients with normal-tension glaucoma (NTG)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Latanoprost (Primary)
- Indications Low tension glaucoma
- Focus Therapeutic Use
- 02 Feb 2016 New trial record